Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
O'Neill WW, Serruys P, Knudtson M, van Es GA, Timmis GC, van der Zwaan C, Kleiman J, Gong J, Roecker EB, Dreiling R, Alexander J, Anders R. O'Neill WW, et al. N Engl J Med. 2000 May 4;342(18):1316-24. doi: 10.1056/NEJM200005043421803. N Engl J Med. 2000. PMID: 10793164 Free article. Clinical Trial.
A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators.
Maillard L, Hamon M, Khalife K, Steg PG, Beygui F, Guermonprez JL, Spaulding CM, Boulenc JM, Lipiecki J, Lafont A, Brunel P, Grollier G, Koning R, Coste P, Favereau X, Lancelin B, Van Belle E, Serruys P, Monassier JP, Raynaud P. Maillard L, et al. J Am Coll Cardiol. 2000 Jun;35(7):1729-36. doi: 10.1016/s0735-1097(00)00612-4. J Am Coll Cardiol. 2000. PMID: 10841218 Free article. Clinical Trial.
Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: the European Antiplatelet Stent Investigation (EASI).
Rothman M, Serruys P, Grollier G, Hoorntje J, van Den Bos A, Wijns W, Gershlick A, Van Es G, Melkert R, Eijgelshoven M, Lenderink T, Richardson G, Dille-Amo C; European Antiplatelet Stent Investigation. Rothman M, et al. Catheter Cardiovasc Interv. 2001 Feb;52(2):249-59. doi: 10.1002/1522-726x(200102)52:2<249::aid-ccd1060>3.0.co;2-t. Catheter Cardiovasc Interv. 2001. PMID: 11170341
Sirolimus-coated Stent Prevents Neointimal Proliferation.
Abizaid A, Dangas G, Costa M, Abizaid A, Sousa A, Serruys PW, Sousa E. Abizaid A, et al. Among authors: serruys pw. Curr Interv Cardiol Rep. 2001 Feb;3(1):1-4. Curr Interv Cardiol Rep. 2001. PMID: 11177714 No abstract available.
Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial.
Kutryk MJ, Foley DP, van den Brand M, Hamburger JN, van der Giessen WJ, deFeyter PJ, Bruining N, Sabate M, Serruys PW; ITALICS Trial. Kutryk MJ, et al. Among authors: serruys pw. J Am Coll Cardiol. 2002 Jan 16;39(2):281-7. doi: 10.1016/s0735-1097(01)01741-7. J Am Coll Cardiol. 2002. PMID: 11788220 Free article. Clinical Trial.
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
Serruys PW, Foley DP, Suttorp MJ, Rensing BJ, Suryapranata H, Materne P, van den Bos A, Benit E, Anzuini A, Rutsch W, Legrand V, Dawkins K, Cobaugh M, Bressers M, Backx B, Wijns W, Colombo A. Serruys PW, et al. J Am Coll Cardiol. 2002 Feb 6;39(3):393-9. doi: 10.1016/s0735-1097(01)01760-0. J Am Coll Cardiol. 2002. PMID: 11823075 Free article. Clinical Trial.
The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.
van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. van den Brand MJ, et al. Among authors: serruys pw. J Am Coll Cardiol. 2002 Feb 20;39(4):559-64. doi: 10.1016/s0735-1097(01)01785-5. J Am Coll Cardiol. 2002. PMID: 11849851 Free article. Clinical Trial.
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. Morice MC, et al. Among authors: serruys pw. N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843. N Engl J Med. 2002. PMID: 12050336 Free article. Clinical Trial.
Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, Guagliumi G, Wijns W, Lindeboom WK, Ligthart J, de Feyter PJ, Morice MC; RAVEL Study Group. Serruys PW, et al. Circulation. 2002 Aug 13;106(7):798-803. doi: 10.1161/01.cir.0000025585.63486.59. Circulation. 2002. PMID: 12176950 Free article. Clinical Trial.
2,706 results